NCT04522388

Brief Summary

This non-randomized pilot study aims to investigate whether a protein rich nutritional shake (Ensure Enlive) given to patients pre-transplant will decrease skeletal muscle loss (measured by quadriceps ultrasound) and improve nutritional state (measured by Nutritional Risk Index). A nutritional supplement would be a cost-effective solution to treat malnutrition, a known risk factor implicated in poor outcomes for lung transplant recipients.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
2

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 18, 2020

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 21, 2020

Completed
3 years until next milestone

Study Start

First participant enrolled

September 1, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 8, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 8, 2024

Completed
Last Updated

June 11, 2025

Status Verified

June 1, 2025

Enrollment Period

4 months

First QC Date

August 18, 2020

Last Update Submit

June 6, 2025

Conditions

Keywords

pre-habnutrition

Outcome Measures

Primary Outcomes (1)

  • Effect of nutritional supplementation on skeletal muscle mass as assessed by ultrasound of the quadriceps

    To examine the effect of nutritional supplementation on skeletal muscle mass in patients with end stage lung disease who are awaiting lung transplant, measured by ultrasound of the quadriceps.

    Pre-transplant

Secondary Outcomes (1)

  • Effect of nutritional supplementation on Nutritional Risk index as assessed by serum albumin level

    Pre-transplant

Study Arms (1)

Treatment

EXPERIMENTAL

Nutritional shakes, Ensure Enlive, twice per day orally in patients awaiting lung transplant

Dietary Supplement: Ensure Enlive

Interventions

Ensure EnliveDIETARY_SUPPLEMENT

Ensure Enlive shake twice a day

Treatment

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subjects 18 years or older who are listed for single or double lung transplant
  • Subject provides written informed consent to participate in this study

You may not qualify if:

  • Subject with history of Galactosemia
  • Subject with history of milk protein allergy
  • Subject with history of soy protein allergy

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Johns Hopkins Hospital

Baltimore, Maryland, 21287, United States

Location

Related Publications (2)

  • Hsu J, Krishnan A, Lin CT, Shah PD, Broderick SR, Higgins RSD, Merlo CA, Bush EL. Sarcopenia of the Psoas Muscles Is Associated With Poor Outcomes Following Lung Transplantation. Ann Thorac Surg. 2019 Apr;107(4):1082-1088. doi: 10.1016/j.athoracsur.2018.10.006. Epub 2018 Nov 14.

    PMID: 30447192BACKGROUND
  • Chamogeorgakis T, Mason DP, Murthy SC, Thuita L, Raymond DP, Pettersson GB, Blackstone EH. Impact of nutritional state on lung transplant outcomes. J Heart Lung Transplant. 2013 Jul;32(7):693-700. doi: 10.1016/j.healun.2013.04.005. Epub 2013 May 9.

    PMID: 23664761BACKGROUND

Related Links

Study Officials

  • Errol Bush, MD

    Johns Hopkins University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Ensure Enlive, Nutritional shake, twice a day
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 18, 2020

First Posted

August 21, 2020

Study Start

September 1, 2023

Primary Completion

January 8, 2024

Study Completion

January 8, 2024

Last Updated

June 11, 2025

Record last verified: 2025-06

Data Sharing

IPD Sharing
Will share

Data sharing will be

Shared Documents
CSR
Time Frame
Data will be available upon completion of the study analysis
Access Criteria
Upon request to principal investigator

Locations